Assessing the role of selected growth factors and cytostatic agents in an in vitro model of human dura mater healing

Neurological Research

Volumn 36, Issue 12, 2014, Pages 1040-1046

  Goldschmidt, Ezequiel ^a   Ielpi, Marcelo ^a   Loresi, Monica ^a   D’Adamo, Maximiliano ^a   Giunta, Diego ^a   Carrizo, Antonio ^a   Ajler, Pablo ^a   Yampolsky, Claudio ^a   Argibay, Pablo ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Chemotherapy; CSF leaks; Dura mater; Growth factors

Indexed keywords

COLCHICINE; CYTOSTATIC AGENT; FIBROBLAST GROWTH FACTOR TYPE 2; GROWTH FACTOR; INSULIN; MITOMYCIN; UNCLASSIFIED DRUG; VINCRISTINE; COLLAGEN; FIBROBLAST GROWTH FACTOR 2; SIGNAL PEPTIDE;

ARTICLE; CELL COUNT; CELL MIGRATION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DURA MATER; EXPLANT; FIBROBLAST; GROWTH CURVE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOSIS; SURGICAL MESH; SURGICAL TECHNIQUE; TISSUE SCAFFOLD; WOUND HEALING; CELL CULTURE; CELL SURVIVAL; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; SERUM;

CELL COUNT; CELL SURVIVAL; CELLS, CULTURED; COLLAGEN; CYTOSTATIC AGENTS; DURA MATER; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HUMANS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; SERUM; WOUND HEALING;

EID: 84919388274     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132814Y.0000000429     Document Type: Article

References (22)

1. Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them. Neurosurgery. 1997;40:11-21; discussion 21-23.
2. Arlt F, Trantakis C, Krupp W, Renner C, Winkler D, Strauss G, et al. Cerebrospinal fluid leak after microsurgical surgery in vestibular schwannomas via retrosigmoidal craniotomy. Neurol Res. 2011;33:947-52.
3. Bayazit YA, Celenk F, Duzlu M, Goksu N. Management of cerebrospinal fluid leak following retrosigmoid posterior cranial fossa surgery. ORL J Otorhinolaryngol Relat Spec. 2009;71:329-33.
4. Goldschmidt E, Landriel F, Bendersky D, Ajler P, Ciraolo C, Carrizo A. Massive subarachnoid pneumocephalus after a stereotactic brain biopsy. Neurol India. 2011;59:640-1.
5. Fishman AJ, Marrinan MS, Golfinos JG, Cohen NL, Roland JT. Prevention and management of cerebrospinal fluid leak following vestibular schwannoma surgery. Laryngoscope. 2004;114:501-5.
6. Gosain AK, Machol JA, Gliniak C, Halligan NLN. TGF-beta1 RNA interference in mouse primary dura cell culture: downstream effects on TGF receptors, FGF-2, and FGF-R1 mRNA levels. Plast Reconstr Surg. 2009;124:1466-73.
7. Nurata H, Cemil B, Kurt G, Uçankus¸ NL, Dogulu F, Omeroğlu S. The role of fibroblast growth factor-2 in healing the dura mater after inducing cerebrospinal fluid leakage in rats. J Clin Neurosci. 2009;16:542-4.
8. Zhou F, Chen G, Zhang J-M, Huang Z-S. An in vitro culturing model for rabbit dural cells. Ann Clin Lab Sci. 2006;36:341-4.
9. Schick B, Wolf G, Romeike BFM, Mestres P, Praetorius M, Plinkert PK. Dural cell culture. A new approach to study duraplasty. Cells Tissues Organs. 2003;173:129-37.
10. Azrad M, Chang P-L, Gower BA, Hunter GR, Nagy TR. Reduced mitogenicity of sera following weight loss in premenopausal women. Nutr Cancer. 2011;63:916-23.
11. Anitua E, Muruzabal F, Alcalde I, Merayo-Lloves J, Orive G. Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery. Exp Eye Res. 2013;115:153-61.
12. Ferguson MK. The effect of antineoplastic agents on wound healing. Surg Gynecol Obstet. 1982;154:421-9.
13. Falcone RE, Nappi JF. Chemotherapy and wound healing. Surg Clin North Am. 1984;64:779-94.
14. Goldschmidt E, Hem S, Ajler P, Ielpi M, Loresi M, Giunta D, et al. A new model for dura mater healing: human dural fibroblast culture. Neurol Res. 2012;35:300-7.
15. Marks MG, Doillon C, Silver FH. Effects of fibroblasts and basic fibroblast growth factor on facilitation of dermal wound healing by type I collagen matrices. J Biomed Mater Res. 1991;25:683-96.
16. Grazul-Bilska AT, Luthra G, Reynolds LP, Bilski JJ, Johnson ML, Adbullah SA, et al. Effects of basic fibroblast growth factor (FGF-2) on proliferation of human skin fibroblasts in type II diabetes mellitus. Exp Clin Endocrinol Diabetes. 2002;110:176-81.
17. Wu HG, Song SY, Kim YS, Oh YT, Lee CG, Keum KC, et al. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional cli. Cancer. 2009;115:3699-708.
18. Carton E, Bellesoeur A, Mir O. Colony-stimulating factors for febrile neutropenia. N Engl J Med. 2013;369:285-6.
19. Shamberger RC, Devereux DF, Brennan MF. The effect of chemotherapeutic agents on wound healing. Int Adv Surg Oncol. 1981;4:15-58.
20. Sakurai T, Jinta E, Suzuma T, Yoshimura G, Umemura T, Sakurai T. Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic diseasea case Report. Gan To Kagaku Ryoho. 2012;39:1703-6.
21. McNamara MG, Sahebjam S, Mason WP. Anaplastic oligodendroglioma: advances and treatment options. Curr Treat Options Neurol. 2013;15:289-301.
22. van den Bent MJ, Brandes AA, Taphoorn MJ, Kros JM, Kouwenhoven MC, Delattre JY, et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol. 2013;31:344-50.